Neumora Therapeutics (NMRA) Other Working Capital Changes (2022 - 2026)
Neumora Therapeutics' (NMRA) quarterly Other Working Capital Changes came in at -$67000.0 in Q1 2026, up 92.68% year-on-year from -$34773.1 in Q1 2025, and up 96.53% quarter-over-quarter from -$1.9 million in Q4 2025.
Neumora Therapeutics (NMRA) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Neumora Therapeutics' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$67000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 92.68% year-over-year to -$67000.0 in Q1 2026; TTM through Mar 2026 was -$1.0 million, a 70.44% increase from a year earlier, with the FY2025 full-year figure at -$1.9 million, up 44.35% from the prior year.
- Other Working Capital Changes rose to -$67000.0 in Q1 2026 per NMRA's latest filing, from -$1.9 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $9.7 million in Q2 2024 and bottomed at -$17.7 million in Q3 2024.
- The 5-year median for Other Working Capital Changes is $90500.0 (2025), against an average of -$93642.9.
- Biggest YoY gain for Other Working Capital Changes was 217.88% in 2025; the steepest drop was 116.46% in 2025.
- Year by year, Other Working Capital Changes stood at $6.2 million in 2022, then slumped by 114.61% to -$913000.0 in 2023, then grew by 2.19% to -$893000.0 in 2024, then tumbled by 116.46% to -$1.9 million in 2025, then surged by 96.53% to -$67000.0 in 2026.
- Per Business Quant, the three latest NMRA Other Working Capital Changes figures stand at -$67000.0 (Q1 2026), -$1.9 million (Q4 2025), and -$1000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Neumora Therapeutics | 280.60 Mn | 280.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -67,000.00 |
| Mar 31, 2026 | -67,000.00 |
| Mar 31, 2026 | -67,000.00 |
| Dec 31, 2025 | -1.93 Mn |
| Dec 31, 2025 | -1.93 Mn |
| Dec 31, 2025 | -1.93 Mn |
| Sep 30, 2025 | -1,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | 969,000.00 |
| Jun 30, 2025 | 969,000.00 |
| Jun 30, 2025 | 969,000.00 |
| Mar 31, 2025 | -915,000.00 |
| Mar 31, 2025 | -915,000.00 |
| Mar 31, 2025 | -915,000.00 |
| Dec 31, 2024 | -893,000.00 |
| Dec 31, 2024 | -893,000.00 |
| Dec 31, 2024 | -893,000.00 |
| Sep 30, 2024 | -861,000.00 |
| Sep 30, 2024 | -861,000.00 |